This invention relates generally to stent delivery apparatuses, and more particularly, but not exclusively, to a stent for gripping a balloon catheter and a mold for fabricating the stent.
Blood vessel occlusions are commonly treated by mechanically enhancing blood flow in the affected vessels, such as by employing a stent. Stents act as scaffoldings, functioning to physically hold open and, if desired, to expand the wall of affected vessels. Typically stents are capable of being compressed, so that they can be inserted through small lumens via catheters, and then expanded to a larger diameter once they are at a desired location. Examples in the patent literature disclosing stents include U.S. Pat. No. 4,733,665 issued to Palmaz, U.S. Pat. No. 4,800,882 issued to Gianturco, and U.S. Pat. No. 4,886,062 issued to Wiktor.
Conventionally, stents are delivered to the desired location by crimping the stent tightly onto a balloon catheter and transporting the crimped stent/balloon catheter combination to the desired location through a patient's vasculature. Alternatively or in addition to the crimping, the balloon catheter is expanded to contact the inner diameter of the stent. At the desired location, the balloon catheter is expanded, thereby expanding the stent to contact the inner diameter of the patient's artery. The balloon catheter is then deflated and removed from the vasculature.
Since the stent and catheter travel through the patient's vasculature, the stent must have a small diameter so that it can pass through small lumens of the patient's vasculature. Secure attachment to the catheter is desirable so that the stent does not prematurely detach from the catheter. The stent should also be sufficiently flexibility to travel through curvatures in the patient's vasculature.
However, conventional crimping techniques can be uneven, leading to sharp edges on the crimped stent that can damage or get caught on the patient's vasculature during delivery. Further, crimping can decrease flexibility of the stent, making it hard to deliver the stent through curvatures in the patient's vasculature.
If the balloon catheter is expanded before delivery, the balloon catheter may cause excessive expansion of the stent, thereby making it hard to transport the stent through the patient's vasculature (e.g., cross tight lesions). Further, expansion of the balloon catheter can cause the distal and proximal ends of the stent to expand further than the rest of the stent, causing the distal and proximal ends to have upward tapered edges that can get caught in the patient's vasculature, thereby decreasing deliverability.
Accordingly, improved methods and devices are desirable for gripping a stent to a balloon catheter that reduce or eliminated the deficiencies mentioned above.
Various embodiments of the present invention include a mold for a radially expandable stent, comprising: a mold member comprising a mold bore including an axial section with a radial cross section that oscillates between a proximal end and a distal end of the mold bore, the axial section being configured to mold a stent mounted on a delivery system to have an oscillating radial cross section along an axial section of the stent, wherein the axial section of the stent improves flexibility of the mounted stent during delivery.
Additional embodiments of the present invention include a mold for a radially expandable stent, comprising: a mold member comprising a mold bore comprising an inner surface along the axis of the mold bore having a wave-like profile, the wave-like profile comprising a first trough, and first crest, a second trough, a second crest, and third trough, a third crest, and a fourth trough extending from the distal to the proximal end of the mold bore.
Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following figures, wherein like reference numerals refer to like parts throughout the various views unless otherwise specified.
The following description is provided to enable any person having ordinary skill in the art to make and use the invention, and is provided in the context of a particular application and its requirements. Various modifications to the embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest scope consistent with the principles, features and teachings disclosed herein.
The term “implantable medical device” is intended to include self-expandable stents, balloon-expandable stents, stent-grafts, and grafts. The structural pattern of the device can be of virtually any design. A stent, for example, may include a pattern or network of interconnecting structural elements or struts.
In some embodiments, a stent may be formed from a tube by laser cutting the pattern of struts in the tube. The stent may also be formed by laser cutting a polymeric or metallic sheet, rolling the pattern into the shape of the cylindrical stent, and providing a longitudinal weld to form the stent. Other methods of forming stents are well known and include chemically etching a sheet and rolling and then welding it to form the stent. A polymeric or metallic wire may also be coiled to form the stent. The stent may be formed by injection molding of a thermoplastic or reaction injection molding of a thermoset polymeric material. Filaments of the compounded polymer may be extruded or melt spun. These filaments can then be cut, formed into ring elements, welded closed, corrugated to form crowns, and then the crowns welded together by heat or solvent to form the stent. Lastly, hoops or rings may be cut from tubing stock, the tube elements stamped to form crowns, and the crowns connected by welding or laser fusion to form the stent.
Additionally, an implantable medical device may be configured to degrade after implantation by fabricating the device either partially or completely from biodegradable polymers. Polymers can be biostable, bioabsorbable, biodegradable, or biocrodable. Biostable refers to polymers that are not biodegradable. The terms biodegradable, bioabsorbable, and bioerodable, as well as degraded, eroded, and absorbed, are used interchangeably and refer to polymers that are capable of being completely eroded or absorbed when exposed to bodily fluids such as blood and can be gradually resorbed, absorbed, and/or eliminated by the body.
Furthermore, a biodegradable device may be intended to remain in the body for a duration of time until its intended function of, for example, maintaining vascular patency and/or drug delivery is accomplished. For biodegradable polymers used in coating applications, after the process of degradation, erosion, absorption, and/or resorption has been completed, no polymer will remain on the stent. In some embodiments, very negligible traces or residue may be left behind. The duration is typically in the range of six to twelve months.
Representative examples of polymers that may be used to fabricate embodiments of implantable medical devices disclosed herein include, but are not limited to, poly(N-acetylglucosamine) (Chitin), Chitosan, poly(3-hydroxyvalerate), poly(lactide-co-glycolide), poly(3-hydroxybutyrate), poly(4-hydroxybutyrate), poly(3-hydroxybutyrate-co -3-hydroxyvalerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(L-lactide-co-D,L-lactide), poly(caprolactone), poly(L-lactide-co-caprolactone), poly(D,L-lactide-co-caprolactone), poly(glycolide-co-caprolactone), poly(trimethylene carbonate), polyester amide, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, biomolecules (such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid), polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefilm copolymers, acrylic polymers and copolymers other than polyacrylates, vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers, polyurethanes, rayon, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose. Additional representative examples of polymers that may be especially well suited for use in fabricating embodiments of implantable medical devices disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluoropropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), ethylene-vinyl acetate copolymers, poly(vinyl acetate), styrene-isobutylene-styrene triblock copolymers, and polyethylene glycol.
In addition, a device may be made of a metallic material or an alloy such as, but not limited to, cobalt chromium alloy (ELGILOY), stainless steel (316L), high nitrogen stainless steel, e.g., BIODUR 108, cobalt chrome alloy L-605, “MP35N,” “MP20N,” ELASTINITE (Nitinol), tantalum, nickel-titanium alloy, platinum-iridium alloy, gold, alloys of cobalt, nickel, chromium and molybdenum available from Standard Press Steel Co., Jenkintown, Pa. “MP35N” consists of 35% cobalt, 35% nickel, 20% chromium, and 10% molybdenum. “MP20N” consists of 50% cobalt, 20% nickel, 20% chromium, and 10% molybdenum.
As discussed above, delivery of a stent is facilitated by a secure attachment of the stent to a delivery system and by flexibility of the stent. A small profile stent (crimped tightly) with a small stent diameter allows for secure attachment and eases transport through narrow lumen passages. However, decreasing a profile of a stent also decreases flexibility of the stent. Conversely, a larger profile stent (expanded stent) with a large stent diameter allows for greater flexibility. However, a large profile makes transport through narrow lumen passages more difficult.
The negative effects on delivery of a small and large profile can be reconciled by using a stent having both large and small profile sections. The small profile sections facilitate secure attachment, while the large profile sections facilitate flexibility. Furthermore, a small profile section at or proximate to a stent end that is a leading end or edge during delivery may be particularly helpful in facilitating delivery. Various embodiments of implantable medical devices, such as stents, having at least these characteristic are disclosed herein.
Certain embodiments of an implantable medical device, such as a radially expandable stent, mounted on a delivery system may include a proximal section tapering inward to a proximal end of the stent and a distal section tapering inward to a distal end of the stent. The tapered sections may be adapted to improve the attachment of the stent to the delivery system. Additionally, the tapered section may facilitate the delivery of the mounted device into and through a bodily lumen.
Facilitating delivery may include facilitating smooth communication of device through a lumen without substantially limiting the ability of device to bend around curvatures in the lumen. Facilitating delivery also may include improving a grip or attachment of the device on the delivery system since. A tapered portion of a device may tend to strengthen a grip of the device on the delivery system. Thus a tapered section may inhibit or prevent disengagement of the device from the delivery system.
In one embodiment, at least a portion of the stent may have a cross-section that is circular or substantially circular. A delivery system may be, for example, a balloon catheter for delivering a stent.
As an illustration,
Accordingly, stent 220 can more easily travel through a patient's vasculature during delivery and is less likely to get caught in or damage the vasculature. Further, since the majority of stent 220 has an expanded profile, stent 220 can still track curvatures in the vasculature.
Additionally, the profile also causes stent 220 to “hug” or grip balloon catheter 210, thereby increasing the ability of stent 220 to stay mounted to the balloon catheter during delivery (until balloon 210 is deflated).
In some embodiments, an implantable medical device, such as a stent, mounted on a delivery system may have a proximal section tapering inward to a proximal end of the stent and a distal section tapering inward to a distal end of the stent. The tapered sections may be adapted to improve the attachment of the stent to the delivery system and to facilitate the delivery of the mounted device into and through a bodily lumen.
In one embodiment, a device may have profile that tapers inward relatively uniformly between the proximal section and the distal section. Thus, the mounted stent may have an “arrow-like” shape. As an illustration,
As indicated above, a small profile at a leading end or edge of a stent is particularly advantageous. To facilitate delivery, the distal end may be a leading edge during delivery. A “leading edge” is the edge of stent that faces the direction of travel during implantation of the stent.
In another embodiment, the proximal section may taper inward relatively uniformly from an intermediate point between the proximal end and the distal end to the proximal end. The distal section may taper inward relatively uniformly from the intermediate point to the distal end.
As an illustration,
In one embodiment, a diameter of a stent that is about 6 mm long and about 0.041 inches in diameter at its midpoint can have a diameter at the distal and proximal ends between about 0.037 inches to about 0.038 inches.
The profile of stents 220, 300, and 410 facilitate a firm attachment of the stents to a balloon catheter, while maintaining flexibility. Further, the stents may travel more easily trough tight lumens due to the small diameter at the ends as compared to conventional stents. Further, the stents are less likely to get caught or damage the patient's vasculature because the stents lack upwardly tapered ends as conventional stents may have after balloon catheter expansion.
In further embodiments, an implantable medical device, such as a stent mounted on a delivery system may include a section having a cross-section that oscillates in size between a proximal section and a distal section. The oscillating cross section may be adapted to improve flexibility during delivery of the mounted stent. Such a stent may have a “wave-like” profile with peaks and troughs.
The section of a stent having a wave-like profile may have at least one narrow region alternating with at least one wide region. At least a portion of the at least one narrow region is in contact with a surface of the delivery system. In addition, at least a portion of the at least one wide region may not be in contact with the surface of the delivery system. Thus, narrow regions may allow the stent to grip a balloon catheter. In addition, the wide regions allow the stent to flex and bend as the mounted stent passes through curved and/or narrow vasculature.
Various embodiments of a mold for implantable medical devices that are described herein may include a mold member having a mold bore configured to mold a stent mounted on a delivery system. The mold member may mold the stent after the delivery system expands an outer surface of the stent onto at least a portion of an inner surface that defines the mold bore.
A mold member may be composed of more than one piece. In some embodiments, the mold member may be composed of two halves. Each half may have a device-holding groove. The grooves may be configured to form the mold bore when the two halves are joined. In one embodiment, the mold may include a lock adapted to inhibit or prevent opening of the mold during molding of the device.
In one embodiment, a mold member may have a projection into a proximal section of a mold bore of the mold member. The projection may be configured to mold a tapered section at a proximal end of an implantable medical device, such as a stent, mounted on a delivery system. The tapered section, as described above, may be adapted to improve the attachment of the stent to the delivery system and facilitate the delivery of the mounted stent into and through a bodily lumen.
In another embodiment, the mold member may have a second projection into a distal section of a mold bore of the mold member for molding a tapered section into a distal end of a stent. In some embodiments, the projection may include a cylindrical member having an annulus disposed within the mold.
As an illustration,
Grooves 620a and 620b form a mold bore 625 (
When balloon catheter 210 is expanded (via internal air pressure), balloon catheter 210 pushes against an inner surface of stent 220, causing stent 220 to expand to match the diameter of bore 625 formed by grooves 620a and 620b. However, since half washers 650 extend into grooves 620a and 620b, the proximal and distal ends of stent 220 cannot expand to the same diameter as the rest of the stent 220 (e.g., to the diameter of bore 625).
Accordingly, stent 220 has a profile after molding in which at least a portion of its proximal and distal ends are tapered inwards. The tapered inward edges facilitate smooth communication of stent 220 through a patient's vasculature without substantially limiting the ability of stent 220 to bend around curvatures in the vasculature. Further, the tapered ends tend to grip the balloon catheter 210 better than untapered ends, inhibiting or preventing stent 220 from disengaging from balloon catheter 210 before it is deflated.
Half 610a includes a first member 630 of a barrel locking mechanism. Half 610b includes a second and third member of the barrel locking mechanism 640a and 640b. Member 630 acts in combination with members 640a and 640b to lock mold 600 after placement of balloon catheter 210 and stent 220 into grooves 610a or 610b and closing mold 600. The barrel locking mechanism inhibits or prevents mold 600 from opening when balloon catheter 210 is expanding.
In alternative embodiments of the invention, different locking mechanisms can be used. Further, halves 610a and 610b need not be coupled together via hinge 615.
In an embodiment of the invention, mold 600 includes only a single pair of half washers 650 that are positioned at one end of stent 220, preferably the leading edge of stent 220 (i.e., the edge of stent 220 that faces the direction of travel during installation of stent 220). Accordingly, stent 220 would have a single tapered end that would facilitate deliverability of stent 220.
Once stent 220 is disposed within bore 625 of closed mold 600, balloon catheter 210 is heated and expanded. Specifically, balloon catheter 210 is heated up to about 190° F to soften balloon catheter 210, thereby causing expansion (referred to as thermogripping). Internal pressure is supplied to the balloon catheter 210 to cause further expansion. Specifically, about 120 PSI to about 330 PSI, or more narrowly about 150 PSI to about 290 PSI, can be applied to cause expansion of catheter 210.
Expansion of balloon catheter 210 causes balloon catheter 210 to press against the inner diameter of stent 220. Expansion of balloon catheter 210 causes a majority of stent 220 to expand to the diameter of bore 625 of mold 600. Half washers 650 prevent ends of stent 220 aligned with the half washers 650 from expanding to the diameter of bore 625 of mold 600. As the ends of the stent 220 press against the half washers 650, the ends of the stent 220 are prevented from expanding, thereby yielding a stent profile with inward tapered ends.
In one embodiment, a mold bore may have a proximal section tapering inward to a proximal end of the mold bore and a distal section tapering inward to a distal end of the mold bore. The tapered sections may be adapted to mold tapered sections of the stent that improve the attachment of the stent to the delivery system and that facilitate the delivery of the mounted stent into and through a bodily lumen. In an embodiment, the mold bore may taper inward relatively uniformly between a proximal section and a distal section.
Delivery of the stent may be facilitated by having the distal end as the end of the stent that faces the direction of delivery. In one embodiment, the distal end or leading end may have a diameter of about 0.038 inches. The diameter may increase to a point proximate to the proximal end to a diameter of about 0.041 inches (e.g., at about 5.5 mm from the leading end in a 6 mm stent). At the proximal end, the diameter may taper off from about 0.041 inches to about 0.038 inches (from about 0.5 mm from the proximal end in a 6 mm stent).
In other embodiments, the mold bore may taper inward relatively uniformly from an intermediate point between a proximal end and a distal end to the proximal end. The mold bore may also taper inward relatively uniformly from the intermediate point to the distal end.
In a further embodiment, a mold bore of a mold member may have a section with a cross-section that oscillates in size between a proximal section and a distal section. The oscillating cross section may be configured to mold a stent mounted on a delivery system to have an oscillating cross section. The oscillating cross section of the stent may improve flexibility of the mounted stent during delivery.
In
In some embodiments, heat may facilitate expansion of the stent. Heat may be applied to the device and/or the delivery system prior to and/or during expanding the device. Heat may be applied by pumping heated fluid into a delivery system, such as balloon catheter. Alternatively heat applied by blowing a heated inert gas (e.g., air, nitrogen, oxygen, argon, etc.) onto the device and/or the delivery system.
While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that changes and modifications can be made without departing from this invention in its broader aspects. Therefore, the appended claims are to encompass within their scope all such changes and modifications as fall within the true spirit and scope of this invention.
This is a divisional application of U.S. application Ser. No. 11/105,004, which was filed on Apr. 12, 2005 and now U.S. Pat. No. 7,381,048, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3687135 | Stroganov et al. | Aug 1972 | A |
3839743 | Schwarcz | Oct 1974 | A |
3900632 | Robinson | Aug 1975 | A |
4104410 | Malecki | Aug 1978 | A |
4110497 | Hoel | Aug 1978 | A |
4130617 | Wallace | Dec 1978 | A |
4264294 | Ruiz | Apr 1981 | A |
4321711 | Mano | Mar 1982 | A |
4346028 | Griffith | Aug 1982 | A |
4596574 | Urist | Jun 1986 | A |
4599085 | Riess et al. | Jul 1986 | A |
4612009 | Drobnik et al. | Sep 1986 | A |
4633873 | Dumican et al. | Jan 1987 | A |
4656083 | Hoffman et al. | Apr 1987 | A |
4718907 | Karwoski et al. | Jan 1988 | A |
4722335 | Vilasi | Feb 1988 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4732152 | Wallstén et al. | Mar 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4739762 | Palmaz | Apr 1988 | A |
4740207 | Kreamer | Apr 1988 | A |
4743252 | Martin, Jr. et al. | May 1988 | A |
4768507 | Fischell et al. | Sep 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4800882 | Gianturco | Jan 1989 | A |
4816339 | Tu et al. | Mar 1989 | A |
4818559 | Hama et al. | Apr 1989 | A |
4850999 | Planck | Jul 1989 | A |
4877030 | Beck et al. | Oct 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4879135 | Greco et al. | Nov 1989 | A |
4886062 | Wiktor | Dec 1989 | A |
4902289 | Yannas | Feb 1990 | A |
4977901 | Ofstead | Dec 1990 | A |
4994298 | Yasuda | Feb 1991 | A |
5019090 | Pinchuk | May 1991 | A |
5028597 | Kodama et al. | Jul 1991 | A |
5059211 | Stack et al. | Oct 1991 | A |
5062829 | Pryor et al. | Nov 1991 | A |
5084065 | Weldon et al. | Jan 1992 | A |
5085629 | Goldberg et al. | Feb 1992 | A |
5100429 | Sinofsky et al. | Mar 1992 | A |
5104410 | Chowdhary | Apr 1992 | A |
5108417 | Sawyer | Apr 1992 | A |
5108755 | Daniels et al. | Apr 1992 | A |
5112457 | Marchant | May 1992 | A |
5123917 | Lee | Jun 1992 | A |
5156623 | Hakamatsuka et al. | Oct 1992 | A |
5163951 | Pinchuk et al. | Nov 1992 | A |
5163952 | Froix | Nov 1992 | A |
5163958 | Pinchuk | Nov 1992 | A |
5167614 | Tessmann et al. | Dec 1992 | A |
5192311 | King et al. | Mar 1993 | A |
5197977 | Hoffman, Jr. et al. | Mar 1993 | A |
5234456 | Silvestrini | Aug 1993 | A |
5234457 | Andersen | Aug 1993 | A |
5236447 | Kubo et al. | Aug 1993 | A |
5279594 | Jackson | Jan 1994 | A |
5282860 | Matsuno et al. | Feb 1994 | A |
5289831 | Bosley | Mar 1994 | A |
5290271 | Jernberg | Mar 1994 | A |
5306286 | Stack et al. | Apr 1994 | A |
5306294 | Winston et al. | Apr 1994 | A |
5328471 | Slepian | Jul 1994 | A |
5330500 | Song | Jul 1994 | A |
5342348 | Kaplan | Aug 1994 | A |
5342395 | Jarrett et al. | Aug 1994 | A |
5342621 | Eury | Aug 1994 | A |
5356433 | Rowland et al. | Oct 1994 | A |
5383925 | Schmitt | Jan 1995 | A |
5385580 | Schmitt | Jan 1995 | A |
5389106 | Tower | Feb 1995 | A |
5399666 | Ford | Mar 1995 | A |
5423885 | Williams | Jun 1995 | A |
5441515 | Khosravi et al. | Aug 1995 | A |
5443458 | Eury et al. | Aug 1995 | A |
5443500 | Sigwart | Aug 1995 | A |
5455040 | Marchant | Oct 1995 | A |
5464650 | Berg et al. | Nov 1995 | A |
5502158 | Sinclair et al. | Mar 1996 | A |
5514379 | Weissleder et al. | May 1996 | A |
5527337 | Stack et al. | Jun 1996 | A |
5545408 | Trigg et al. | Aug 1996 | A |
5554120 | Chen et al. | Sep 1996 | A |
5556413 | Lam | Sep 1996 | A |
5578046 | Liu et al. | Nov 1996 | A |
5578073 | Haimovich et al. | Nov 1996 | A |
5591199 | Porter et al. | Jan 1997 | A |
5591607 | Gryaznov et al. | Jan 1997 | A |
5593403 | Buscemi | Jan 1997 | A |
5593434 | Williams | Jan 1997 | A |
5599301 | Jacobs et al. | Feb 1997 | A |
5599922 | Gryaznov et al. | Feb 1997 | A |
5605696 | Eury et al. | Feb 1997 | A |
5607442 | Fischell et al. | Mar 1997 | A |
5607467 | Froix | Mar 1997 | A |
5618299 | Khosravi et al. | Apr 1997 | A |
5629077 | Turnlund et al. | May 1997 | A |
5630830 | Verbeek | May 1997 | A |
5631135 | Gryaznov et al. | May 1997 | A |
5632771 | Boatman et al. | May 1997 | A |
5632840 | Campbell | May 1997 | A |
5637113 | Tartaglia et al. | Jun 1997 | A |
5649977 | Campbell | Jul 1997 | A |
5653691 | Rupp et al. | Aug 1997 | A |
5667767 | Greff et al. | Sep 1997 | A |
5667796 | Otten | Sep 1997 | A |
5670558 | Onishi et al. | Sep 1997 | A |
5672169 | Verbeek | Sep 1997 | A |
5693085 | Buirge et al. | Dec 1997 | A |
5700286 | Tartaglia et al. | Dec 1997 | A |
5707385 | Williams | Jan 1998 | A |
5711763 | Nonami et al. | Jan 1998 | A |
5716981 | Hunter et al. | Feb 1998 | A |
5725549 | Lam | Mar 1998 | A |
5726297 | Gryaznov et al. | Mar 1998 | A |
5728751 | Patnaik | Mar 1998 | A |
5733326 | Tomonto et al. | Mar 1998 | A |
5733330 | Cox | Mar 1998 | A |
5733564 | Lehtinen | Mar 1998 | A |
5733925 | Kunz et al. | Mar 1998 | A |
5741881 | Patnaik | Apr 1998 | A |
5756457 | Wang et al. | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5759474 | Rupp et al. | Jun 1998 | A |
5765682 | Bley et al. | Jun 1998 | A |
5766204 | Porter et al. | Jun 1998 | A |
5766239 | Cox | Jun 1998 | A |
5766710 | Turnlund et al. | Jun 1998 | A |
5769883 | Buscemi et al. | Jun 1998 | A |
5780807 | Saunders | Jul 1998 | A |
5800516 | Fine et al. | Sep 1998 | A |
5811447 | Kunz et al. | Sep 1998 | A |
5824049 | Ragheb et al. | Oct 1998 | A |
5830178 | Jones et al. | Nov 1998 | A |
5830461 | Billiar et al. | Nov 1998 | A |
5830879 | Isner | Nov 1998 | A |
5833651 | Donovan et al. | Nov 1998 | A |
5834582 | Sinclair et al. | Nov 1998 | A |
5836962 | Gianotti | Nov 1998 | A |
5837313 | Ding et al. | Nov 1998 | A |
5837835 | Gryaznov et al. | Nov 1998 | A |
5840083 | Braach-Maksvytis | Nov 1998 | A |
5851508 | Greff et al. | Dec 1998 | A |
5853408 | Muni | Dec 1998 | A |
5854207 | Lee et al. | Dec 1998 | A |
5855612 | Ohthuki et al. | Jan 1999 | A |
5855618 | Patnaik et al. | Jan 1999 | A |
5858746 | Hubbell et al. | Jan 1999 | A |
5865814 | Tuch | Feb 1999 | A |
5868781 | Killion | Feb 1999 | A |
5873904 | Ragheb et al. | Feb 1999 | A |
5874101 | Zhong et al. | Feb 1999 | A |
5874109 | Ducheyne et al. | Feb 1999 | A |
5874165 | Drumheller | Feb 1999 | A |
5876743 | Ibsen et al. | Mar 1999 | A |
5877263 | Patnaik et al. | Mar 1999 | A |
5879713 | Roth et al. | Mar 1999 | A |
5888533 | Dunn | Mar 1999 | A |
5891192 | Murayama et al. | Apr 1999 | A |
5897955 | Drumheller | Apr 1999 | A |
5906759 | Richter | May 1999 | A |
5914182 | Drumheller | Jun 1999 | A |
5916870 | Lee et al. | Jun 1999 | A |
5922005 | Richter et al. | Jul 1999 | A |
5942209 | Leavitt et al. | Aug 1999 | A |
5948428 | Lee et al. | Sep 1999 | A |
5954744 | Phan et al. | Sep 1999 | A |
5957975 | Lafont et al. | Sep 1999 | A |
5965720 | Gryaznov et al. | Oct 1999 | A |
5971954 | Conway et al. | Oct 1999 | A |
5976182 | Cox | Nov 1999 | A |
5980564 | Stinson | Nov 1999 | A |
5980928 | Terry | Nov 1999 | A |
5980972 | Ding | Nov 1999 | A |
5981568 | Kunz et al. | Nov 1999 | A |
5986169 | Gjunter | Nov 1999 | A |
5997468 | Wolff et al. | Dec 1999 | A |
6010445 | Armini et al. | Jan 2000 | A |
6015541 | Greff et al. | Jan 2000 | A |
6042875 | Ding et al. | Mar 2000 | A |
6048964 | Lee et al. | Apr 2000 | A |
6051648 | Rhee et al. | Apr 2000 | A |
6056993 | Leidner et al. | May 2000 | A |
6060451 | DiMaio et al. | May 2000 | A |
6066156 | Yan | May 2000 | A |
6071266 | Kelley | Jun 2000 | A |
6074659 | Kunz et al. | Jun 2000 | A |
6080177 | Igaki et al. | Jun 2000 | A |
6080488 | Hostettler et al. | Jun 2000 | A |
6083258 | Yadav | Jul 2000 | A |
6093463 | Thakrar | Jul 2000 | A |
6096070 | Ragheb et al. | Aug 2000 | A |
6096525 | Patnaik | Aug 2000 | A |
6099562 | Ding et al. | Aug 2000 | A |
6103230 | Billiar et al. | Aug 2000 | A |
6107416 | Patnaik et al. | Aug 2000 | A |
6110188 | Narciso, Jr. | Aug 2000 | A |
6113629 | Ken | Sep 2000 | A |
6117979 | Hendriks et al. | Sep 2000 | A |
6120536 | Ding et al. | Sep 2000 | A |
6120904 | Hostettler et al. | Sep 2000 | A |
6121027 | Clapper et al. | Sep 2000 | A |
6125523 | Brown et al. | Oct 2000 | A |
6127173 | Eckstein et al. | Oct 2000 | A |
6129761 | Hubbell | Oct 2000 | A |
6129928 | Sarangapani et al. | Oct 2000 | A |
6150630 | Perry et al. | Nov 2000 | A |
6153252 | Hossainy et al. | Nov 2000 | A |
6159951 | Karpeisky et al. | Dec 2000 | A |
6160084 | Langer et al. | Dec 2000 | A |
6165212 | Dereume et al. | Dec 2000 | A |
6166130 | Rhee et al. | Dec 2000 | A |
6169170 | Gryaznov et al. | Jan 2001 | B1 |
6171609 | Kunz | Jan 2001 | B1 |
6174330 | Stinson | Jan 2001 | B1 |
6177523 | Reich et al. | Jan 2001 | B1 |
6183505 | Mohn, Jr. et al. | Feb 2001 | B1 |
6187045 | Fehring et al. | Feb 2001 | B1 |
6210715 | Starling et al. | Apr 2001 | B1 |
6224626 | Steinke | May 2001 | B1 |
6228845 | Donovan et al. | May 2001 | B1 |
6240616 | Yan | Jun 2001 | B1 |
6245076 | Yan | Jun 2001 | B1 |
6245103 | Stinson | Jun 2001 | B1 |
6248344 | Ylanen et al. | Jun 2001 | B1 |
6251135 | Stinson et al. | Jun 2001 | B1 |
6251142 | Bernacca et al. | Jun 2001 | B1 |
6273913 | Wright et al. | Aug 2001 | B1 |
6281262 | Shikinami | Aug 2001 | B1 |
6284333 | Wang et al. | Sep 2001 | B1 |
6287332 | Bolz et al. | Sep 2001 | B1 |
6290485 | Wang | Sep 2001 | B1 |
6290721 | Heath | Sep 2001 | B1 |
6293966 | Frantzen | Sep 2001 | B1 |
6303901 | Perry et al. | Oct 2001 | B1 |
6312459 | Huang et al. | Nov 2001 | B1 |
6327772 | Zadno-Azizi et al. | Dec 2001 | B1 |
6375826 | Wang et al. | Apr 2002 | B1 |
6379381 | Hossainy et al. | Apr 2002 | B1 |
6387117 | Arnold et al. | May 2002 | B1 |
6387121 | Alt | May 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6395326 | Castro et al. | May 2002 | B1 |
6409761 | Jang | Jun 2002 | B1 |
6423092 | Datta et al. | Jul 2002 | B2 |
6461632 | Gogolewski | Oct 2002 | B1 |
6464720 | Boatman et al. | Oct 2002 | B2 |
6479565 | Stanley | Nov 2002 | B1 |
6481262 | Ching et al. | Nov 2002 | B2 |
6485512 | Cheng | Nov 2002 | B1 |
6492615 | Flanagan | Dec 2002 | B1 |
6494908 | Huxel et al. | Dec 2002 | B1 |
6495156 | Wenz et al. | Dec 2002 | B2 |
6511748 | Barrows | Jan 2003 | B1 |
6517888 | Weber | Feb 2003 | B1 |
6527801 | Dutta | Mar 2003 | B1 |
6537589 | Chae et al. | Mar 2003 | B1 |
6539607 | Fehring et al. | Apr 2003 | B1 |
6540774 | Cox | Apr 2003 | B1 |
6540777 | Stenzel | Apr 2003 | B2 |
6554854 | Flanagan | Apr 2003 | B1 |
6561788 | Gaudoin | May 2003 | B1 |
6565599 | Hong et al. | May 2003 | B1 |
6569191 | Hogan | May 2003 | B1 |
6569193 | Cox et al. | May 2003 | B1 |
6572672 | Yadav et al. | Jun 2003 | B2 |
6574851 | Mirizzi | Jun 2003 | B1 |
6585755 | Jackson et al. | Jul 2003 | B2 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6592617 | Thompson | Jul 2003 | B2 |
6613072 | Lau et al. | Sep 2003 | B2 |
6626939 | Burnside et al. | Sep 2003 | B1 |
6635269 | Jennissen | Oct 2003 | B1 |
6645243 | Vallana et al. | Nov 2003 | B2 |
6656162 | Santini, Jr. et al. | Dec 2003 | B2 |
6664335 | Krishnan | Dec 2003 | B2 |
6666214 | Canham | Dec 2003 | B2 |
6667049 | Janas et al. | Dec 2003 | B2 |
6669723 | Killion et al. | Dec 2003 | B2 |
6676697 | Richter | Jan 2004 | B1 |
6679980 | Andreacchi | Jan 2004 | B1 |
6689375 | Wahlig et al. | Feb 2004 | B1 |
6695920 | Pacetti et al. | Feb 2004 | B1 |
6706273 | Roessler | Mar 2004 | B1 |
6709379 | Brandau et al. | Mar 2004 | B1 |
6719934 | Stinson | Apr 2004 | B2 |
6719989 | Matsushima et al. | Apr 2004 | B1 |
6720402 | Langer et al. | Apr 2004 | B2 |
6726713 | Schaldach et al. | Apr 2004 | B2 |
6746773 | Llanos et al. | Jun 2004 | B2 |
6752826 | Holloway et al. | Jun 2004 | B2 |
6753007 | Haggard et al. | Jun 2004 | B2 |
6764505 | Hossainy et al. | Jul 2004 | B1 |
6776604 | Chobotov et al. | Aug 2004 | B1 |
6818063 | Kerrigan | Nov 2004 | B1 |
6846323 | Yip et al. | Jan 2005 | B2 |
6911041 | Zscheeg | Jun 2005 | B1 |
6948223 | Shortt | Sep 2005 | B2 |
7055237 | Thomas | Jun 2006 | B2 |
7097440 | Papp et al. | Aug 2006 | B2 |
20010044652 | Moore | Nov 2001 | A1 |
20020002399 | Huxel et al. | Jan 2002 | A1 |
20020004060 | Heublein et al. | Jan 2002 | A1 |
20020004101 | Ding et al. | Jan 2002 | A1 |
20020062148 | Hart | May 2002 | A1 |
20020065553 | Weber | May 2002 | A1 |
20020077690 | Wang | Jun 2002 | A1 |
20020099406 | St. Germain | Jul 2002 | A1 |
20020111590 | Davila et al. | Aug 2002 | A1 |
20020116050 | Kocur | Aug 2002 | A1 |
20020138133 | Lenz et al. | Sep 2002 | A1 |
20020161114 | Gunatillake et al. | Oct 2002 | A1 |
20030033001 | Igaki | Feb 2003 | A1 |
20030093107 | Parsonage et al. | May 2003 | A1 |
20030100865 | Santini, Jr. et al. | May 2003 | A1 |
20030105518 | Dutta | Jun 2003 | A1 |
20030105530 | Pirhonen | Jun 2003 | A1 |
20030171053 | Sanders | Sep 2003 | A1 |
20030187495 | Cully et al. | Oct 2003 | A1 |
20030208259 | Penhasi | Nov 2003 | A1 |
20030209835 | Chun et al. | Nov 2003 | A1 |
20030226833 | Shapovalov et al. | Dec 2003 | A1 |
20030236565 | DiMatteo et al. | Dec 2003 | A1 |
20040093077 | White et al. | May 2004 | A1 |
20040098095 | Burnside et al. | May 2004 | A1 |
20040111149 | Stinson | Jun 2004 | A1 |
20040127970 | Saunders et al. | Jul 2004 | A1 |
20040143317 | Stinson et al. | Jul 2004 | A1 |
20040167610 | Fleming, III | Aug 2004 | A1 |
20040249435 | Andreas | Dec 2004 | A1 |
Number | Date | Country |
---|---|---|
44 07 079 | Sep 1994 | DE |
197 31 021 | Jan 1999 | DE |
19746882 | Apr 1999 | DE |
198 56 983 | Dec 1999 | DE |
0 108 171 | May 1984 | EP |
0 144 534 | Jun 1985 | EP |
0 364 787 | Apr 1990 | EP |
0 397 500 | Nov 1990 | EP |
0 464 755 | Jan 1992 | EP |
0 493 788 | Jul 1992 | EP |
0 554 082 | Aug 1993 | EP |
0 578 998 | Jan 1994 | EP |
0 604 022 | Jun 1994 | EP |
0 621 017 | Oct 1994 | EP |
0 623 354 | Nov 1994 | EP |
0 665 023 | Aug 1995 | EP |
0 709 068 | May 1996 | EP |
0 970 711 | Jan 2000 | EP |
2 247 696 | Mar 1992 | GB |
WO 8903232 | Apr 1989 | WO |
WO 9001969 | Mar 1990 | WO |
WO 9004982 | May 1990 | WO |
WO 9006094 | Jun 1990 | WO |
WO 9117744 | Nov 1991 | WO |
WO 9117789 | Nov 1991 | WO |
WO 9210218 | Jun 1992 | WO |
WO 9306792 | Apr 1993 | WO |
WO 9421196 | Sep 1994 | WO |
WO 9529647 | Nov 1995 | WO |
WO 9740780 | Nov 1997 | WO |
WO 9804415 | Feb 1998 | WO |
WO 9903515 | Jan 1999 | WO |
WO 9916386 | Apr 1999 | WO |
WO 9942147 | Aug 1999 | WO |
WO 0012147 | Mar 2000 | WO |
WO 0049973 | Aug 2000 | WO |
WO 0064506 | Nov 2000 | WO |
WO 0101890 | Jan 2001 | WO |
WO 02066095 | Aug 2002 | WO |
WO 2004023985 | Mar 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20080254159 A1 | Oct 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11105004 | Apr 2005 | US |
Child | 12101044 | US |